Bank Of New York Mellon Corp Amgen Inc Transaction History

Bank Of New York Mellon Corp

$528 Trillion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $1.22 Billion - $1.49 Billion	5,414,740 New	5,414,740 $0
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $1.26 Billion - $1.6 Billion	5,514,763 New	5,514,763 $1.45 Billion
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $2.55 Million - $2.88 Million	-11,375 Reduced 0.19%	5,969,543 $1.35 Billion
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $10.2 Million - $11.4 Million	-44,247 Reduced 0.73%	5,980,918 $1.46 Billion
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $61.5 Million - $68.1 Million	-280,575 Reduced 4.45%	6,025,165 $1.46 Billion
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $66.6 Million - $76.3 Million	335,068 Added 5.61%	6,305,740 $1.42 Billion
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $2.4 Million - $2.81 Million	-11,300 Reduced 0.19%	5,970,672 $1.27 Billion
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $96.6 Million - $107 Million	-413,740 Reduced 6.47%	5,981,972 $1.46 Billion
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $26.7 Million - $31.2 Million	-120,477 Reduced 1.85%	6,395,712 $1.59 Billion
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $74.8 Million - $89.1 Million	-345,684 Reduced 5.04%	6,516,189 $1.5 Billion
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $41.9 Million - $46.6 Million	178,623 Added 2.67%	6,861,873 $1.74 Billion
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $34 Million - $41.7 Million	171,906 Added 2.64%	6,683,250 $1.58 Billion
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $53.7 Million - $71.2 Million	-294,594 Reduced 4.33%	6,511,344 $1.32 Billion
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $1.52 Million - $1.96 Million	8,049 Added 0.12%	6,805,938 $1.64 Billion
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $18.6 Million - $22.3 Million	106,998 Added 1.6%	6,797,889 $1.32 Billion
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $31.7 Million - $37.1 Million	-190,065 Reduced 2.76%	6,690,891 $1.23 Billion
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $7.39 Million - $8.33 Million	40,838 Added 0.6%	6,880,956 $1.31 Billion
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $64.4 Million - $75.2 Million	-361,153 Reduced 5.02%	6,840,118 $1.33 Billion
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $13.2 Million - $14.9 Million	-71,116 Reduced 0.98%	7,201,271 $0
Q2 2018 Aug 06, 2018	SELL	$166.05 - $186.51 $36.1 Million - $40.6 Million	-217,483 Reduced 2.9%	7,272,387 $1.34 Billion
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $87.7 Million - $103 Million	-517,735 Reduced 6.47%	7,489,870 $1.28 Billion
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $1.35 Billion - $1.51 Billion	8,007,605	8,007,605 $1.39 Billion

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account